Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients
about
sameAs
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndromeClinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adultsSystematic review: macrophage activation syndrome in inflammatory bowel diseaseAdult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine AMacrophage activation syndrome in a child with systemic juvenile rheumatoid arthritisMacrophage activation syndrome: advances towards understanding pathogenesisMacrophage activation syndrome induced by A/H1N1 influenza in cystic fibrosis.Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature.Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patientsReactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patientsMacrophage Activation Syndrome.Acute hepatitis in three patients with systemic juvenile idiopathic arthritis taking interleukin-1 receptor antagonistImportance of hyperbilirubinemia in differentiation of primary and secondary hemophagocytic lymphohistiocytosis in pediatric cases.How I treat hemophagocytic lymphohistiocytosis.Modern management of children with haemophagocytic lymphohistiocytosis.Hodgkin's lymphoma, Epstein-Barr virus reactivation and fatal haemophagocytic syndrome.Systemic arthritis in children: a review of clinical presentation and treatmentHemophagocytic syndrome secondary to adult-onset Still's disease but very similar to lymphomaEvidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritisHypocomplementemia associated with macrophage activation syndrome in systemic juvenile idiopathic arthritis and adult onset still's disease: 3 cases.Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan.The common causes leading to pancytopenia in patients presenting to tertiary care hospital.How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis.Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy.Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India.Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment.Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis.Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis.Macrophage activation syndrome and cytokine-directed therapies.Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.Clinical features and correct diagnosis of macrophage activation syndrome.2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation CollMacrophage activation syndrome in the era of biologic therapy.The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
P2860
Q24798867-2D0C99DD-EDAA-46B0-B05D-51B8611D7E76Q26852503-D0AD3ECA-18B5-47AD-9252-218AF44E4985Q27025349-F0414F21-EB64-475B-AE61-7D165D4792D5Q28167268-7EECBF01-AA67-44BC-908A-DBB012419E2AQ28187372-EC52286C-343B-40CB-A06A-5B204980C140Q28284000-4B414D25-FA8B-4939-BADA-B7FF22434F3DQ30427095-B76CC34F-A0A7-4FFA-B1E7-62D80A2B29C0Q33370577-D190343D-1DBD-4838-A873-00F88CC48A94Q33386883-B193607F-20EF-4350-88EB-C189E86F9DA8Q33401348-FFC16DBC-4A4D-4B1B-AD45-B5C0F32E1CDFQ33414047-014010EB-E128-4904-A13E-3E1FB71066FDQ33420069-7CA8D82E-2C40-41AC-94C1-71552CA4BF35Q33426151-95C29C0E-35B6-47FC-92C8-1103164F7FB6Q33587308-F6602BD0-1F6C-4A9E-BE7D-82C6CA43B4FFQ34532052-183DBE2C-2E55-4A8F-9FC9-CD2DB042F667Q35483540-09AF74A1-5BA0-4341-B64C-A4287D2FB08DQ35607712-5623A12A-619A-42F6-94E4-A03E2DC502FFQ35640337-F049570C-641C-436C-9A8F-6950CDD68430Q35659928-C076301F-164E-4093-9907-06F30CFFFC06Q36003228-F585DA1E-9B73-4582-A413-70261A99A3E5Q36346681-6E39E2F4-C064-4F5A-ADED-7522ACC692ABQ36420991-6901E4DE-061C-40D1-8924-2C0634AD4BF7Q36901665-08E25350-4890-4840-AA93-C1630E819CD3Q36915642-F572C3B6-EC93-4C8F-80DA-B4DB0A988120Q37235737-0C11474B-106F-4CA8-8FBA-91002168AEA3Q37382639-67EF6E22-1354-4047-89E8-57D413887CE1Q37387929-CCA967F4-23BD-44BD-B18E-F7193E69D6D3Q37729056-B1755275-A1DF-431B-80CB-5F8E4A18BA72Q37827375-98FC2BA1-A70C-404E-82AA-78654730302FQ37993678-8AB0B2DF-26CB-4484-9EB4-398FE3542624Q38064531-849565FA-7235-420F-918D-7DFBFDC27E3CQ38161412-FD127A84-5E40-48A6-97B8-32DBEF21FFCAQ38224085-ED002817-81C0-4E69-9E70-6B8E1B42828BQ38267068-D9DEE2B0-CF57-4DBD-B2FA-C47A39230032Q38406386-D78F4615-7CC7-4587-950D-ECE4FDF2BBA0Q38530013-7974AF72-7851-427C-A9A0-694ACD79563DQ38575277-5A78B81B-9134-4126-AB18-41625E06B6A9Q38786756-06D71A51-761F-441C-BEBD-59742AAC6D27Q38925320-BF429EB1-D6AC-4819-A22C-C5B07876E01DQ40093291-FC7FB976-4B6D-470D-84E7-621220A45156
P2860
Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Reactive haemophagocytic syndr ...... ospective study of 24 patients
@ast
Reactive haemophagocytic syndr ...... ospective study of 24 patients
@en
Reactive haemophagocytic syndr ...... ospective study of 24 patients
@nl
type
label
Reactive haemophagocytic syndr ...... ospective study of 24 patients
@ast
Reactive haemophagocytic syndr ...... ospective study of 24 patients
@en
Reactive haemophagocytic syndr ...... ospective study of 24 patients
@nl
prefLabel
Reactive haemophagocytic syndr ...... ospective study of 24 patients
@ast
Reactive haemophagocytic syndr ...... ospective study of 24 patients
@en
Reactive haemophagocytic syndr ...... ospective study of 24 patients
@nl
P2093
P356
P1433
P1476
Reactive haemophagocytic syndr ...... ospective study of 24 patients
@en
P2093
A M Prieur
C Galambrun
I Koné-Paut
J L Stéphan
P304
P356
10.1093/RHEUMATOLOGY/40.11.1285
P407
P577
2001-11-01T00:00:00Z